Delivery Order SPE2DB22D2206-SPE2DB24FJP01
Award Date
8/1/24
Potential Completion Date
8/2/24
Potential Value
$7.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $1,213.62, is for the delivery of GRANIX 300 MCG/0.5 ML SAFE SYR 0.5ML, a specialty pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 18, 2023. The contract is not designated as a set-aside. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,932.26, is a delivery order for the supply of GRANIX 300 MCG/0.5 ML SAFE SYR 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 29, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,285.32, is for the delivery of GRANIX 480 MCG/0.8 ML SAFE SYR 0.8ML, a specialty pharmaceutical product. The contract has a period of performance through November 29, 2023 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GRANIX 480 MCG/0.8 ML SAFE SYR 0.8ML, a pharmaceutical product, with a ceiling value of $12,660.99 and a period of performance through December 3, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,096,500 units of the pharmaceutical product GRANIX 480 MCG/0.8 ML SAFE SYR 0.8ML. The contract has a firm fixed price of $8,824.41 and a completion date of July 10, 2024. This is a delivery order contract, and there is no set-aside designation mentioned. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $1,213.62 to Amerisourcebergen Drug Corporation for 4562185573 GRANIX 300 MCG/0.5 ML SAFE SYR 0.5ML. Performance will occur in Conshohocken, Pennsylvania under the prime contractor's corporate office division. The order is associated with the Defense Logistics Agency's medical supply chain and will provide Granix, a medication used to treat neutropenia. Amerisourcebergen Corporation is the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,253.70 firm-fixed-price delivery order is for the supply of GRASTEK 2,800 BAU SL Tablets. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $8,864.40, is for the delivery of GRALISE ER 300 MG TABLET 90S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of November 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $3,122.21 for the supply of GRALISE ER 300 MG TABLET 90S. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 26, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a...